PRODUODOPA
On the Bulgarian pack: Продуодопа 240 mg/ml + 12 mg/ml инфузионен разтвор
240 mg/ml + 12 mg/ml · Solution for infusion
- Prescription only
- Pain, sleep, mood, epilepsy and the brain
- Active substance
- Foslevodopa and decarboxylase inhibitor
- Made by
- AbbVie Deutschland GmbH & Co.KG
- Source
- Official label
Quoted from the official source. Not yet reviewed by Mediclarum — the leaflet in your pack is authoritative.
What it is for
Mediclarum has not yet read the official leaflet for this product. The exact uses and dose are in the leaflet inside the pack. Open the official leaflet
Same active substance, strength and form in other countries
Matched on active substance, strength and kind of form only. This is not a statement that the products are equivalent or interchangeable: other ingredients, release and approved uses can differ — ask a pharmacist before swapping.
Medicine passport: one printable page to show a pharmacist abroad
Spain1 matching products
CanadaNo exact match for this strength and form
NetherlandsNo exact match for this strength and form
Details
| Made by | AbbVie Deutschland GmbH & Co.KG · Germany |
|---|---|
| Active substance | Foslevodopa and decarboxylase inhibitor |
| Used in | Pain, sleep, mood, epilepsy and the brain |
| Strength | 240 mg/ml + 12 mg/ml |
| Form | Solution for infusion |
| Pack sizes | 7 |
| Classification | N04BA07 · Pain, sleep, mood, epilepsy and the brain |
| Name in the register | Продуодопа 240 mg/ml + 12 mg/ml инфузионен разтвор |
| Reg. no. | 20220287 |
Source: Bulgarian Drug Agency register · 2026-08-01 · not reviewed by a clinician
Източник: Изпълнителна агенция по лекарствата (ИАЛ). The publisher’s terms do not grant reproduction, so text is shortened and linked. Publisher’s terms.